图像辅助反感寡核酸输送用于瘤向基因治疗
Hanwen Liao1, Siyi Wang1, Xiaoning Wang1
1State Key Laboratory of Analytical Chemistry for Life Sciences, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University, Nanjing 210023, China.
Chemical & biomedical imaging
|October 30, 2024
概括
反感性寡核酸 (ASOs) 通过向瘤基因来治疗癌症有望出现. 将分子成像与输送车辆相结合,可以提高ASO向瘤的分布,从而改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 反感 oligonucleotides (ASOs) 正在成为有效的工具,以准以前无法药物治疗的瘤基因.
- 目前,一些ASO候选药物正在进行癌症治疗的临床试验.
- 评估ASO的有效性和准确性需要先进的评估方法.
研究的目的:
- 审查分子成像技术和传送工具的协同组合,以实现增强的反感性寡核酸 (ASO) 传送.
- 探索改善ASO在瘤部位的分布和积累的策略.
- 为了优化基于反感的癌症治疗的治疗结果.
主要方法:
- 对有关ASO交付策略的当前文献进行系统审查.
- 探索分子成像技术,以对ASO进行定性和定量评估.
- 对旨在增强寡核酸生物分布和瘤积累的输送车辆的分析.
主要成果:
- 分子成像为ASO的药理动力学和生物分布提供了关键的见解.
- 结合成像和输送车辆的协同方法可以显著提高ASO瘤向.
- 优化交付可以提高ASO的疗效和治疗潜力.
结论:
- 分子成像与先进的传递系统的整合对于推进反感性寡核酸治疗方法至关重要.
- 这种综合方法提供了一种强大的策略,可以提高基于ASO的癌症治疗的疗效和精度.
- 在这个领域进行进一步的研究对开发更有效的瘤基因向疗法具有重大前景.
相关概念视频
Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K


